Blood cell study for inherited ichthyosis with NIPAL4 gene mutation
Treatments studied
Part of Blood & lymphatic, Cancer, Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at blood cells in people with a rare form of ichthyosis caused by NIPAL4 gene mutations. It aims to understand how the immune system might be affected, which could help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a type of ichthyosis caused by a change in the NIPAL4 gene (confirmed by genetic testing).
- You cannot have other inflammatory, infectious, or blood disorders.
- You cannot be under legal guardianship, curatorship, or other protective measures.
- You must be willing to participate and not object to the research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.
This study follows people with rare “autoinflammatory” conditions and sometimes their blood relatives to understand why symptoms happen and how they change over time. It may help by improving diagnosis and care for these conditions, using stored samples and genetic testing.
This study looks for genetic causes of immune problems, such as unusually frequent infections, abnormal allergies, or autoimmune or inflammation conditions. It may help by improving how doctors understand these disorders and by matching families with possible genetic diagnoses.
This study tests whether an antibiotic called gentamicin, given as an injection, can improve symptoms of hereditary ichthyosis, a genetic skin condition that causes severe dryness and scaling. If you have moderate to severe ichthyosis due to certain gene changes, this treatment might help your skin produce the missing proteins.
This study creates special lab cell lines from skin (or nasal) samples from people with immune system disorders and certain family members. It’s meant to help researchers build tools to better study these conditions using patient cells.
This study uses a new blood test to find and monitor people with APDS, a rare immune disease, who may be helped by the drug leniolisib. It aims to improve how doctors screen and track treatment response.
Hear when a new Sezary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.